Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Acta Anaesthesiol Scand ; 49(8): 1200-6, 2005 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16095463

RESUMEN

BACKGROUND: Hypotension associated with spinal anesthesia for cesarean section is still a clinical problem. Colloid solutions seem preferable to crystalloid solutions for preloading. In most studies the overall rate of hypotension is reported. Few studies have, however, investigated the maternal and neonatal consequences of different levels of maternal hypotension. METHODS: In this randomized, double-blinded study 110 patients presenting for elective cesarean section received either 1000 ml acetated Ringer's solution or 1000 ml 3% dextran 60 solution immediately before spinal anesthesia. The effect on overall hypotension, clinically significant hypotension (hypotension associated with maternal discomfort defined as nausea, retching/vomiting, dizziness or chest symptoms) and severe hypotension (systolic arterial pressure <80 mmHg) was studied. RESULTS: Dextran reduced the incidence of overall hypotension from 85 to 66% (P=0.03), reduced the incidence of clinically significant hypotension from 60 to 30% (P=0.002) and reduced the incidence of severe hypotension from 23 to 3.6% (P=0.004) compared to Ringer's solution. There were neither differences in neonatal outcome between treatment groups nor between neonates grouped after severity of maternal hypotension. CONCLUSION: Clinically significant hypotension seems to be a more suitable outcome variable than overall hypotension. The protective effect of the colloid solution increased with increased severity of hypotension.


Asunto(s)
Anestesia Obstétrica/efectos adversos , Anestesia Raquidea/efectos adversos , Cesárea/métodos , Dextranos/uso terapéutico , Hipotensión/prevención & control , Sustitutos del Plasma/uso terapéutico , Cuidados Preoperatorios/métodos , Adulto , Puntaje de Apgar , Dióxido de Carbono/sangre , Estimulantes del Sistema Nervioso Central/uso terapéutico , Cesárea/efectos adversos , Coloides/uso terapéutico , Soluciones Cristaloides , Método Doble Ciego , Procedimientos Quirúrgicos Electivos/métodos , Efedrina/uso terapéutico , Femenino , Humanos , Concentración de Iones de Hidrógeno/efectos de los fármacos , Hipotensión/etiología , Recién Nacido , Soluciones Isotónicas/uso terapéutico , Valores de Referencia , Solución de Ringer , Arterias Umbilicales/efectos de los fármacos
2.
Int J Obstet Anesth ; 13(3): 178-82, 2004 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15321398

RESUMEN

The ex utero intrapartum treatment (EXIT) procedure is a method of maintaining utero-placental circulation during cesarean section to gain time to secure a potentially obstructed fetal airway. Four cases of the EXIT procedure are described with special reference to the maternal anesthetic technique. Deep volatile anesthesia (approximately 2 MAC) with isoflurane or sevoflurane for a prolonged period of time, in three cases in combination with an intravenous nitroglycerin infusion, was used to ensure a fully relaxed uterus during the procedure. All mothers were maintained hemodynamically stable with preserved utero-placentary perfusion. It was possible to intubate the tracheas of two fetuses, whereas in the other two tracheostomies had to be performed. Fetal gas exchange was not negatively affected during the EXIT procedure as evidenced by normal blood gas values in the umbilical artery at the time of delivery. After reducing the concentration of volatile anesthetic, delivery of the neonate and administration of oxytocin, uterine contractility was promptly re-established and there were no signs of uterine atony in the postoperative period. All four neonates survived the procedure without complications.


Asunto(s)
Obstrucción de las Vías Aéreas/congénito , Obstrucción de las Vías Aéreas/terapia , Anestesia por Inhalación , Anestesia Obstétrica , Cesárea/métodos , Adulto , Anestésicos por Inhalación , Quistes/congénito , Quistes/terapia , Femenino , Hipoxia Fetal/prevención & control , Hipoxia Fetal/terapia , Neoplasias de Cabeza y Cuello/congénito , Neoplasias de Cabeza y Cuello/terapia , Humanos , Recién Nacido , Intubación Intratraqueal , Isoflurano , Laringoestenosis/congénito , Laringoestenosis/terapia , Masculino , Éteres Metílicos , Enfermedades de la Boca/congénito , Enfermedades de la Boca/terapia , Nitroglicerina/uso terapéutico , Embarazo , Sevoflurano , Tocolíticos/uso terapéutico , Traqueostomía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA